WAF1/CIP1/SDI1 gene is an important regulator of crucial cellular processes, including cell cycle control, cellular dierentiation, and the response to genotoxic stress. Induction of p21 gene expression upon DNA damage is widely believed to be p53-dependent. In the present study we analysed the expression of p21 following genotoxic stress, using dierent DNA-damaging agents and cellular systems. We found that the p21 response markedly varied between dierent cell lines and also for dierent genotoxic agents within the same cell line. Genotoxic induction of p21 mRNA expression can occur in the presence of p53-antagonists, such as overexpressed mdm-2 or human papillomavirus (HPV) E6, and in cells harbouring mutated p53 genes. Moreover, upon genotoxic stress, p21 mRNA and protein expression were found to be uncoupled in several cell lines. Thus, transcriptional and postranscriptional changes in p21 expression following DNA damage are not necessarily linked to the intracellular p53 status but strongly depend on the individual cellular background and the type of DNA-damaging agent. Our ®ndings indicate that p21 expression following genotoxic stress underlies a complex control and can be substantially modulated on the posttranscriptional level in a cellspeci®c manner.
Introduction
Several independent experimental approaches led to the identi®cation and molecular cloning of the human p21 WAF1/CIP1/SDI1 gene, in the following abbreviated as p21 (El-Deiry et al., 1993; Harper et al., 1993; Xiong et al., 1993; Noda et al., 1994) . The p21 gene appears to be involved in several crucial regulatory processes within the cell. Its expression has been found to be upregulated during dierentiation of dierent cell types, including keratinocytes (Missero et al., 1995) and myoblasts (Parker et al., 1995) , and during cellular senescence of human ®broblasts . These observations may be partly related to the ability of p21 protein to interact with a broad range of cyclindependent kinases, thereby inhibiting their activities and blocking cell cycle progression (Harper et al., 1993; Xiong et al., 1993) . Under certain conditions, however, the p21 protein can also exhibit stimulatory eects on the activity of cyclin-dependent kinases (Zhang et al., 1994; LaBaer et al., 1997) . In addition, by virtue of its ability to directly bind to PCNA, the p21 protein can inhibit DNA replication (Waga et al., 1994) . Furthermore, p21 may play a role in DNA repair (McDonald III et al., 1996; Sheikh et al., 1997) and in the regulation of DNA methylation (Chuang et al., 1997) . Experimentally, p21 can block the tumorigenic phenotype of cancer cells in vitro and in vivo, blocking cell proliferation and inducing terminal dierentiation (Yang et al., 1995; Zeng et al., 1997) .
Activation of p21 gene expression can be dependent or independent of wildtype (wt) p53. Several p53-independent activators of p21 transcription have been recently identi®ed, including MyoD (Halevy et al., 1995) , WT1 (Englert et al., 1997) , gax , AP-2 , C/EBPa (Timchenko et al., 1996) , BRCA (Somasundraram et al., 1997) , and the p53-related p73 protein (Kaghad et al., 1997) . Activation of p21 may contribute to the growth inhibitory and/or dierentiation-promoting activities of these factors. In addition, p21 appears to be an important mediator of the p53-associated cellular response to DNA damage. Cells de®cient of p21 no longer exhibit cell cycle arrest in G1 following treatment with genotoxic agents (Brugarolas et al., 1995; Waldman et al., 1995) . The p21 gene contains de®ned p53-recognition elements within its promoter region (El-Deiry et al., 1993) which may mediate the induction of p21 gene expression by DNA-damaging agents (El-Deiry et al., 1994; Michieli et al., 1994; MacLeod et al., 1995) .
In the present study, we compared p21 gene expression upon treatment with dierent DNAdamaging agents in a series of cell lines which dier in their endogenous p53 status, i.e. cells containing wt p53, cells expressing cellular or viral p53-antagonists, or cells with p53 gene defects. Our results demonstrate that the regulation of p21 expression following DNA damage is highly dependent on the cellular background and on the type of genotoxic agent, but is not necessarily linked to the p53 status. Strikingly, p21 mRNA and protein levels were severely uncoupled in several cell lines, even exhibiting inverse correlations, indicating that p21 expression following genotoxic stress can be strongly modulated on the posttranscriptional level.
and primary cells were treated with the alkylating agent mitomycin C (mitC). As expected, treatment of primary keratinocytes containing wt p53 led to a clear induction of p21 mRNA levels ( Figure 1a) . Similarly, we detected increased p21 gene expression in a series of human cancer cell lines containing wt p53, such as RKO colon cancer, HepG2 hepatoma, MCF-7 breast carcinoma, and HT1080 ®brosarcoma cells, and, as previously reported (Butz et al., 1995) , in the HPVpositive cervical cancer cell lines C4-I, C4-II, SW756, Me180, and CaSKi. Under the same experimental conditions, p21 mRNA levels did not increase in HPVpositive SiHa cervical cancer cells. A strong induction of p21 mRNA levels was observed in wt p53-containing OsA-CL-cells, a sarcoma cell line which overexpresses the p53-antagonistic mdm-2 gene (Oliner et al., 1992) . While p21 mRNA levels were almost undetectable in p53-mutant C33A cervical cancer cells, a clear increase in p21 gene expression following mitC treatment was observed in HPV-negative HT3 cervical carcinoma cells, which also contain mutant (mt) p53 (Schener et al., 1991) (Figure 1a ). This indicates that induction of p21 gene expression following mitC treatment, at least in certain cells, does not require wt p53. This is further supported by the ®nding that mitC also induced p21 mRNA levels in H1299 lung cancer cells, which do not express p53 due to homozygous deletions within both p53 alleles (Mitsudomi et al., 1992) .
We next investigated the regulation of p21 expression following mitC treatment on the protein level (Figure 1b) . With the exception of CaSKi cells, there was a positive correlation between the induction of p53 protein and p21 mRNA in all cell lines containing wildtype (wt) p53 genes (Figure 1a and b) . In primary keratinocytes and some tumor cell lines (RKO, HepG2, MCF-7, HT1080, C4-II and SiHa), p21 mRNA levels qualitatively correlated with p21 protein levels upon genotoxic stress (Figure 1a and b) , although some quantitative dierences were observed. For example, in primary keratinocytes or RKO cells, the induction of p21 is much stronger on the protein level than on the mRNA level. Strikingly, however, despite signi®cant upregulation of p21 mRNA levels, there was no marked increase of p21 protein levels in C4-I, Me180, CaSki, HT3 and OsA-CL cells. Moreover, SW756 cells even showed an inverse correlation, exhibiting a drastic reduction of p21 protein levels ( Figure 1b ) at strongly increased mRNA levels ( Figure 1a) .
To analyse the dierences in p21 expression in more detail, kinetic studies following mitC treatment were performed in CaSKi, C4-II, and SW756 cells. Clear increases of p21 mRNA levels were observed in all three cell lines, starting approximately 2 ± 4 h following mitC treatment (Figure 2a ). While p21 protein levels remained largely unchanged over the complete time period of 24 h in CaSKi cells, they strongly increased in C4-II cells starting at 14 h after treatment and continuously decreased in SW756 cells starting at 4 h following treatment (Figure 2b ). The latter observation indicates that down-modulation of p21 protein expression in SW756 cells is a continuous process after DNA damage and does not follow a possible peak of increased p21, which may have been missed by analysis of only the 24 h time point (Figure 1 ).
In parallel, we also investigated the kinetic regulation of p53 protein levels and HPV E6/E7 oncogene expression, since the latter has been shown previously to be reduced by mitC (Butz et al., 1996) . Downmodulation of E6/E7 gene expression was initiated at later time points than p21 mRNA induction and, as shown for CaSKi, did not necessarily result in increased p53 protein levels ( Figure 2b ). The decrease of E6/E7 mRNA expression correlated with a a b n.d. The downmodulation of p21 protein expression despite increased p21 mRNA levels in SW756 cells could be due to a substantial reduction of the half-life of the p21 protein following genotoxic stress. To investigate this possibility, untreated or mitC-treated C4-II and SW756 cells were exposed to the translational inhibitor cycloheximide and the half-life of p21 was determined in time course experiments by Western blot analysis. For both cell lines, the half-life of p21 did not exhibit substantial dierences between untreated and mitC exposed cells (Figure 3) . Quantitation by densitometric scanning indicates a p21 protein halflife of approximately 40 min in both cell lines. Thus, the strong decrease in p21 protein levels observed upon genotoxic stress in SW756 cells (Figures 1 and 2) does not appear to be due to a reduction in protein half-life.
Next, we examined whether other genotoxic agents could also uncouple p21 mRNA and protein expression or whether these observations were a peculiarity of the alkylating agent mitC. In this set of experiments, we employed cisplatin, UV-irradiation, and g-irradiation as genotoxic agents. Cisplatin forms metal complexes with DNA and primarily results in interand intrastrand DNA crosslinks, UV-irradiation typically results in pyrimidine-dimers and the 6-4 photoproduct, and g-irradiation primarily causes single-and double-stranded DNA strand breaks (Whitaker, 1992) . As target cells, we used cell lines exhibiting dierential responses to mitC, namely C4-II (both p21 mRNA and protein levels up-regulated), SW756 (p21 mRNA upregulated, protein downregulated), SiHa (p21 mRNA down-regulated and protein downregulated), and CaSKi (p21 mRNA upregulated, protein unchanged). In parallel, we also investigated p53 protein levels and HPV E6/E7 gene expression under genotoxic treatment with these agents.
As shown in Figure 4a , treatment with cisplatin led to clearly increased p21 mRNA levels in all four cell lines. On the protein level, and alike mitC, cisplatin treatment resulted in a concomitant increase of p21 expression only in C4-II, while p21 mRNA and protein levels did not correlate in SW756, CaSKi, and SiHa cells (Figure 4a and b) . Under the experimental conditions of this study, UV-irradiation exhibited less pronounced eects on p21 mRNA levels, when compared to cisplatin, with lower levels of induction in all four cell lines (Figure 4a ). In contrast to the RNA data, p21 protein levels decreased in CaSKi, SiHa, and SW756 cells following UV-irradiation, while they remained largely unchanged in C4-II cells. These results show that there are signi®cant discrepancies between p21 mRNA and protein levels also following treatment with cisplatin and UV-irradiation. In addition, under identical experimental conditions, individual cell lines appear to be dierentially aected, depending on the type of DNA damaging agent used. It is also noteworthy that UV-irradiation, alike mitC and cisplatin, resulted in a down-modulation of E6/E7 oncogene expression and E7 oncoprotein levels in HPV-positive cancer cells (Figure 4) .
Kinetic studies were performed to analyse the eects of g-irradiation on p21 regulation. Again, the in¯uence of this genotoxic agent on p21 expression markedly diered between the investigated cell lines (Figure 5a ). All cell lines exhibited an elevation of p21 RNA levels over the whole 24 h time period, which in C4-II cells was only weak and showed a peak at approximately 3 h following irradiation. The increase in p21 mRNA levels was accompanied on the protein level by an apparent lack of p21 induction in SiHa cells, a transient induction at 3 h in C4-II cells, prolongued induction of p21 protein starting at approximately 12 h in CaSKi cells and slightly decreasing p21 protein levels in SW756 cells. In contrast to mitC, cisplatin, and UV-irradiation, g-irradiation did not result in a reduction of viral E6/E7 mRNA (Figure 5a ) or E7 oncoprotein levels (Figure 5b ) under conditions where p21 mRNA levels were upregulated.
Discussion
The results of this study show that the regulation of p21 expression following genotoxic stress is strongly dependent on the cellular background and the type of DNA damaging agent. Moreover, there can be substantial discrepancies between intracellular p21 mRNA and protein levels, indicating that posttranscriptional events can strongly in¯uence p21 expression following DNA damage.
The discrepancies between p21 mRNA and protein levels following genotoxic stress, as observed in this work, are reminiscent of those occuring during dierentiation. Uncoupling of p21 mRNA and protein levels has been observed during the dierentiation of MEL cells (MacLeod et al., 1995) , where small increases of p21 RNA were accompanied by large increases of p21 protein levels, and during later stages of calcium-induced dierentiation of keratinocytes (Missero et al., 1996) , where p21 mRNA levels stayed upregulated, while p21 protein levels decreased. Also, transcription factor C/EBPa, which is involved in adipocyte dierentiation, has been reported to induce p21 expression partly by stabilization of p21 protein (Timchenko et al., 1996) . Thus, our ®ndings indicate that, similar to p21 regulation during dierentiation, the expression of p21 following genotoxic stress can be substantially in¯uenced on the posttranscriptional level.
Uncoupling of p21 mRNA and protein levels could even lead to inverse correlations, such as in SW756 cells following mitC, cisplatin, and UV treatment, where there was a concomitant up-regulation of RNA levels and down-regulation of protein levels. Although p21 protein levels can be principally regulated through modulation of protein stability, for example during induction of p21 protein levels by CEBPa (Timchenko et al., 1996) , we did not obtain experimental evidence for an alteration of p21 half-life following genotoxic stress. Thus, it appears that reduction of p21 protein levels in SW756 cells is not due to protein destabilization. Also, for several cell lines, we did not observe a linear correlation between p53 and p21 protein levels. Such a correlation has been found in human breast epithelial cells following ionizing radiation, leading to the suggestion that the p53 protein can directly aect p21 protein levels (Gudas et al., 1995) . In addition, while the E7 protein of dierent HPV types can bind p21 (Funk et al., 1997; and has the potential to destabilize its cellular binding partner pRb (Boyer et al., 1996; , we also did not observe a consistent correlation between HPV18 E7 and p21 protein levels under genotoxic stress in the HPV-positive cancer cell lines. Thus, at this point, mechanisms other than increased protein degradation which uncouple p21 mRNA from protein expression must be considered, including alterations of RNA transport and/or translational regulation. More work is required to investigate these possibilities in detail.
Following the identi®cation of p21 as a target gene for p53-mediated transactivation, several studies indicated that induction of p21 gene expression by genotoxic agents required functional p53 (El-Deiry et al., 1994; Michieli et al., 1994; MacLeod et al., 1995) . Although we also observed that induction of p21 mRNA correlated in most cells with increased p53 protein levels, the genotoxic induction of p21 transcripts in p53-mutant HT3 or p53-negative H1299 cells indicates that this process underlies a complex regulation and does not necessarily depend on functional p53. This is in contrast to the widespread notion that genotoxic induction of p21 expression generally requires wt p53 and indicates the existence of p53-independent pathways by which genotoxic stress can induce p21 (Johnson et al., 1994; Sheikh et al., 1994; Loignon et al., 1997) .
Interestingly, both p53 protein and p21 transcripts were clearly detectable and strongly inducible by mitC treatment in OsA-CL sarcoma cells. These cells endogenously overexpress Mdm-2 (Oliner et al., 1992) , which recently has been reported to induce rapid degradation of p53 following ectopic expression (Haupt et al., 1997; Kubbutat et al., 1997) . Thus, p53 and p53-associated pathways appear to be principally inducible by genotoxic stress in a tumor cell line endogenously overexpressing a cellular p53-antagonist. This parallels the behaviour of many HPV-positive cancer cell lines expressing the E6 gene, a viral antagonist of p53. As previously reported (Butz et al., 1995) , a series of HPV-positive cancer cell lines exhibited increased p21 transcript levels following treatment with dierent genotoxic agents. We observed a variation in the response of HPV-positive SiHa cells towards mitC treatment which in the present study did not result in elevated p53 protein and p21 transcript levels, possibly due to dierences between the SiHa strains used in the two studies. Nevertheless, these ®ndings indicate that the endogenous levels of Mdm-2 in Osa-CL and HPV E6 in several HPVpositive cancer cell lines, respectively, are limited in their ability to abrogate p53 induction following genotoxic stress.
Analyses of HPV-positive cancer cell lines showed that the viral E6/E7 oncogene expression was downmodulated by UV-irradiation, similar as observed before following mitC or cisplatin treatment (Butz et al., 1996) . The changes in E6/E7 expression did not necessarily correlate with the alterations of p21 expression under genotoxic stress and uncoupling of p21 mRNA and protein expression was also observed in HPV-negative cells. These ®ndings suggest that the discrepancies between p21 mRNA and protein levels in several HPV-positive cancer cell lines are not due to eects of the viral oncoproteins. Regarding the regulation of HPV gene expression under genotoxic stress, it is noteworthy that E6/E7 expression was not down-modulated following treatment with g-irradiation, which primarily results in DNA strand breaks (Whitaker, 1992) . This raises the possibility that the reduction of E6/E7 oncogene expression in HPVpositive cancer cells is not a general response to genotoxic stress, but may depend on the type of DNA lesion. Work is in progress to conclusively answer this issue.
Taken together, the results of this study have several new implications for the understanding of the cellular response to genotoxic stress. Regulation of p21 expression following DNA damage can be strongly variable and is highly dependent on the cellular background. Induction of p21 mRNA following genotoxic stress can occur in the presence of viral and cellular p53-antagonists and, at least in some cell lines, does not require wt p53. In addition, dierent types of DNA damaging agents also dier in their capacity to induce p21 mRNA and protein. Moreover, again depending on the cellular context and the type of genotoxic agent, p21 mRNA expression can be markedly uncoupled from protein expression, indicating that p21 expression following DNA damage is strongly modulated on the posttranscriptional level.
Materials and methods

Cell culture and genotoxic treatment
Primary human cervical keratinocytes CxK2 and CxK4 were grown in keratinocyte growth medium (KGM Bulletkit, Clonetics, USA). All other cells were maintained in Dulbecco's minimal essential medium (pH 7.2) supplemented with 10% fetal calf serum. HPV16-positive SiHa and CaSKi, HPV18 positive C4-I, C4-II, and SW756, HPV68-positive Me180 cervical carcinoma, RKO colon cancer, HepG2 hepatoma, MCF-7 breast cancer, HT1080 ®brosarcoma, and OsA-CL sarcoma cells all contain wt p53 (Schener et al., 1991; Oliner et al., 1992) . HPVnegative C33A and HT3 cervical cancer cells express mt p53 (Schener et al., 1991) , while H1299 lung cancer cells do not express p53 protein due to intragenic p53 deletions in both alleles (Mitsudomi et al., 1992) .
For genotoxic treatment, exponentially growing cells were exposed to either 10 mg/ml mitomycin C (Sigma, Deisenhofen, Germany), 10 mg/ml cisplatin (ASTA Medica, Frankfurt, Germany), 50 J/m 2 UV-radiation (UV Stratalinker 2400, Stratagene, Heidelberg, Germany), or 20 gy g-irradiation using a 137 Cs source (Gammacell 1000, Atomic Energy of Canada Ltd., Canada), respectively. Unless otherwise indicated, cells were harvested approximately 24 h following treatment for further analysis.
Northern and Western blot analyses, determination of protein half-life
For Northern blot analyses, RNA was isolated by acid guanidinium-thiocyanate-phenol-chloroform extraction (Chomczynski and Sacchi, 1987) . Approximately 5 mg RNA were separated on a 1% agarose gel and analysed by using a p21 cDNA fragment (NotI digest of pC-WAF1-S, El-Deiry et al., 1993), a 683 bp fragment of the E6/E7 region of HPV18 (EcoRI ± HindIII fragment), or a 1.3 kb fragment (EcoRI/PstI) of the HPV16 E6/E7 region as radiolabeled hybridization probes, respectively. To verify RNA integrity and to account for loading variations between individual lanes, RNA gels were stained with ethidium bromide and GAPDH was used as a control probe.
For Western blot analyses, protein was prepared essentially as described before (Butz et al., 1995) . Unless otherwise indicated, approximately 20 mg of protein was analysed by enhanced chemoluminescence (ECL kit, Amersham, USA), using the monoclonal anti-p21 antibody WAF1 (Ab1) (Dianova, Hamburg, Germany), the monoclonal antip53 antibody DO-1 (Pharmingen, San Diego, USA), or the anti-HPV18 E7 antibody 18E7C as primary antibodies, respectively. Antibody 18E7C was raised in chicken against a fusion protein consisting of HPV18E7 linked to six histidine residues at its N-terminus.
Protein and RNA were prepared from duplicate tissue culture dishes identically treated in the same experimental setting to allow a direct comparison of these parameters within the same cell line. Unless otherwise indicated, identical amounts of RNA and protein were analysed for each cell line in Northern and Western blots, respectively.
For the determination of p21 protein half-life, cells were treated with 10 mg/ml mitomycin C for 14 h. Subsequently, treated and untreated control cells were exposed to 20 mg/ml cycloheximide for dierent time points, as indicated in the text, harvested for protein extraction and analysed by Western blot as described above. For estimation of protein half-life, signal intensities were quantitated by densitometric scanning using the Scan Jet IIc (Hewlett Packard, San Diego, USA).
